Atlas Trials

Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Clinical trial NCT04189679 · COMPLETED

Trial details

NCT number
NCT04189679
Sponsor
University Hospital, Grenoble
Status
COMPLETED
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer
Start date
2020-01-03
Primary completion
2023-01-27
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.